会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 27. 发明授权
    • LENTILLE INTRAOCULAIRE CONTENANT UN MEDICAMENT RELARGABLE
    • LENTILLE INTRAOCULAIRE CONTENTANT UNARMAMENT RELARGABLE
    • EP0954341B1
    • 2007-02-28
    • EP97951333.0
    • 1997-12-15
    • Ioltechnologie-Production
    • AIACHE, Jean-MarcSERPIN, GilbertEL MESKI, SaidTOURRETTE, Philippe
    • A61L27/54A61F2/16
    • A61L27/54A61L2300/41A61L2300/602A61L2430/16
    • The invention relates to an intraocular lens, of a hard or soft material, intended for implantation in the eye of a subject, and notably for substitution during a surgical operation of a defective crystalline lens. The lens comprises a polymer with a specified hydrophilic rate, containing a medicated product spread throughout its mass, the effects of which are suited to the circumstances of the operation, and in particular the at least partial inhibition of the post-operative reactions of the eye. The combination of the polymer and the medicated product results in the gradual release of the product into the aqueous humor. The figure herewith demonstrates the evolution of the indomethacin content in the aqueous humor and plasma of a rabbit implanted with a hydroxyethyl methacrylate lens containing in its mass this anti-inflammatory. Clinically, the inflammatory response had disappeared prior to the second day.
    • 本发明涉及用于植入对象眼睛中的硬或软材料的人工晶状体,特别是用于在有缺陷晶状体的外科手术过程中进行替代。 该镜片包含具有特定亲水速率的聚合物,其含有散布在其整个团块中的药物,其作用适合于手术情况,特别是至少部分抑制眼睛的手术后反应 。 聚合物和加药产品的组合导致产品逐渐释放到房水中。 本图显示了植入甲基丙烯酸羟乙酯晶状体的兔子的房水和血浆中吲哚美辛含量的变化,所述甲基丙烯酸羟乙基酯晶状体大量含有这种抗炎剂。 临床上,炎症反应在第二天之前已经消失。